{"transactions":[{"id":2741781,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":140083,"kind":"person","name":"Hilt Dana Charles","position":1,"cik":"0001360756","reported_name":"Hilt Dana Charles","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-04-22T16:18:39.000Z","date":"2021-04-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest as to 50% on February 14, 2022 and 50% on July 4, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001127602-21-014287","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1360756/000112760221014287/form4.xml","form_type":"4"}},{"id":2904015,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":140083,"kind":"person","name":"Hilt Dana Charles","position":1,"cik":"0001360756","reported_name":"Hilt Dana Charles","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2021-01-19T16:57:55.000Z","date":"2021-01-15","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2021, and will be fully vested and exercisable on January 1, 2025."}],"balance_after":70000,"derivative":{"exercise_price":35.85,"expiration_date":"2031-01-14","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001127602-21-001988","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1360756/000112760221001988/form4.xml","form_type":"4"}},{"id":3270057,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":140083,"kind":"person","name":"Hilt Dana Charles","position":1,"cik":"0001360756","reported_name":"Hilt Dana Charles","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2020-02-14T16:22:40.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2020, and will be fully vested and exercisable on January 1, 2024."}],"balance_after":50000,"derivative":{"exercise_price":25.05,"expiration_date":"2030-02-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001127602-20-005638","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1360756/000112760220005638/form4.xml","form_type":"4"}}]}